BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:48 PM
Feb 08, 2010
 |  BC Extra  |  Clinical News

Cara presents CR845 data

Cara Therapeutics Inc. (Shelton, Conn.) reported data from a Phase II trial of CR845 to treat acute...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >